CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 3,359,045	$ 7,151,800
Accounts receivable, net of allowance of $75,000 at December 31, 2023 and September 30, 2023, respectively	450,757	255,502
Inventories	377,291	330,027
Prepaid expenses and other current assets	402,953	389,241
Total current assets	4,590,046	8,126,570
Property and equipment, net	539,319	838,270
Other assets:
Restricted cash	750,000	750,000
Intangible assets	2,698,975	2,698,975
Operating right of use asset	1,117,317	1,237,762
Capitalized transaction costs	217,553
Total assets	9,913,210	13,651,577
Current liabilities:
Accounts payable and accrued liabilities	2,023,876	2,270,388
Operating lease liability, current	510,028	498,598
Deferred revenue	54,035	76,435
Total current liabilities	2,587,939	2,845,421
Long term accrued liabilities	31,467	31,467
Deferred revenue, long term	227,999	194,000
Operating lease liability, long term	607,288	739,162
Deferred tax liability, net	684,115	684,115
Warrants classified as a liability	1,646,000	4,285,000
Total liabilities	5,784,808	8,779,165
Commitments and contingencies (Note G)
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of Decenber 31, 2023 and September 30 2023, respectively
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2023 and September 30, 2023, 13,721,820 and 13,658,520 shares issued and outstanding as of December 31, 2023 and September 30, 2023, respectively	13,722	13,659
Additional paid in capital	307,848,612	307,384,647
Accumulated deficit	(303,630,004)	(302,447,147)
Applied DNA Sciences, Inc. stockholders' equity	4,232,330	4,951,159
Noncontrolling interest	(103,928)	(78,747)
Total equity	4,128,402	4,872,412
Total liabilities and equity	9,913,210	13,651,577
Series A Preferred stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of Decenber 31, 2023 and September 30 2023, respectively
Series B Preferred stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of Decenber 31, 2023 and September 30 2023, respectively